Pioneering innovative API manufacturing solutions

Driven by the curiosity, skills and dedication of over 2,000 employees on three continents, we innovate and collaborate as a pharma company with more than 900 customers to deliver sustainable, technologically-advanced API products and services benefitting millions of patients on the planet.

Explore our group
antibody drug conjugates manufacturing services in Le Mans

Our Group in numbers

>0 million
patients served this year
>0
customers over the last 3 years
>0
years of experience
>0
customer audits over the last 3 years

One group. Three stories.

Millions of patients served.

Expertise across the world

Discover our network

Novasep CDMO strengthens its innovative position in oncology

We invested €8 million in our Le Mans (Fr) site to expand our production capabilities for manufacturing ADCs. Behind every pharma project, there are high-quality services for our customers and cutting-edge drugs for millions of patients worldwide.

Read the press release

Combining strengths to provide existing and innovative treatments for patients

“Axplora possess a unique blend of technical expertise (chromatography and small molecule manufacturing), interpersonal skills, and a dedication to excellence that makes them an exceptional CMO. We are fortunate to have such a strong partnership with the Axplora team!”

PARATEK PHARMA

Partnership Paratek Axplora

“The Axplora team was very open, flexible and efficient in working through project changes.”

US BIOTECH

Novasep CDMO, part of Axplora manufactures ADC payloads

Martin Meeson - CEO

DCAT Value Chain Insights - Industry Roundtable: Small-Molecule APIs - January 2025

"The continued rising demand for complex APIs, particularly in areas such as GLP-1 receptor agonists for metabolic disorders and antibody-drug conjugates (ADCs) for oncology, increases the need for advanced manufacturing expertise and specialized facilities."